OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 26 filers reported holding OPIANT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24,000 | +84.6% | 1,200 | -2.7% | 0.00% | – |
Q3 2022 | $13,000 | -23.5% | 1,233 | -11.9% | 0.00% | – |
Q2 2022 | $17,000 | -43.3% | 1,400 | 0.0% | 0.00% | – |
Q1 2022 | $30,000 | -25.0% | 1,400 | +16.7% | 0.00% | – |
Q4 2021 | $40,000 | +29.0% | 1,200 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | +93.8% | 1,200 | 0.0% | 0.00% | – |
Q2 2021 | $16,000 | +23.1% | 1,200 | 0.0% | 0.00% | – |
Q1 2021 | $13,000 | +30.0% | 1,200 | 0.0% | 0.00% | – |
Q4 2020 | $10,000 | 0.0% | 1,200 | -6.2% | 0.00% | – |
Q3 2020 | $10,000 | -16.7% | 1,280 | +0.2% | 0.00% | – |
Q2 2020 | $12,000 | 0.0% | 1,277 | +1.4% | 0.00% | – |
Q1 2020 | $12,000 | -29.4% | 1,259 | +4.9% | 0.00% | – |
Q4 2019 | $17,000 | -15.0% | 1,200 | -8.1% | 0.00% | – |
Q3 2019 | $20,000 | +25.0% | 1,306 | +8.8% | 0.00% | – |
Q2 2019 | $16,000 | – | 1,200 | +23900.0% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 5 | -99.9% | 0.00% | – |
Q2 2018 | $55,000 | +1733.3% | 3,788 | +2512.4% | 0.00% | – |
Q4 2017 | $3,000 | -57.1% | 145 | -27.5% | 0.00% | – |
Q3 2017 | $7,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 112,000 | $2,399,000 | 2.90% |
Ovata Capital Management Ltd | 117,865 | $2,525,000 | 0.78% |
HealthInvest Partners AB | 18,000 | $386,000 | 0.62% |
PERRITT CAPITAL MANAGEMENT INC | 30,500 | $653,000 | 0.35% |
Parkman Healthcare Partners LLC | 32,557 | $697,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 32,040 | $686,000 | 0.08% |
DLD Asset Management, LP | 20,000 | $428,000 | 0.03% |
Newbridge Financial Services Group, Inc. | 2,050 | $44,000 | 0.02% |
Trexquant Investment LP | 12,013 | $257,000 | 0.01% |
BAILARD, INC. | 15,042 | $322,000 | 0.01% |